GONG Pu-yang, YIN Ke-huan, LI Xue-dong, GU Jian, TAN Rui. Clinical and pharmacological research progress of Tibetan medicine in prevention and treatment for hepatic fibrosisJ. Acta Pharmaceutica Sinica, 2021,56(11): 2995-3003. doi: 10.16438/j.0513-4870.2021-0264
Citation: GONG Pu-yang, YIN Ke-huan, LI Xue-dong, GU Jian, TAN Rui. Clinical and pharmacological research progress of Tibetan medicine in prevention and treatment for hepatic fibrosisJ. Acta Pharmaceutica Sinica, 2021,56(11): 2995-3003. doi: 10.16438/j.0513-4870.2021-0264

Clinical and pharmacological research progress of Tibetan medicine in prevention and treatment for hepatic fibrosis

  • Hepatic fibrosis is a common pathological link of multiple chronic liver diseases, and further causes cirrhosis and even liver cancer. Tibetan medicine possessed significant and unique clinical effects in the prevention and treatment of hepatic fibrosis through unique medication methods such as single prescription, time synergy, and dialectical combination prescription. Pharmacological experimental studies have shown that a variety of Tibetan medicine formulas and herbs have anti-fibrotic effects, and their main pharmacological action mechanism involves inhibiting lipid peroxidation, reducing liver stellate cell activation and proliferation, regulating collagen metabolism, etc. This review summarizes the research progress of the clinical application and pharmacodynamic mechanism of Tibetan medicine in the prevention and treatment of liver fibrosis, aiming to provide a reference for the development of clinical use and innovative drugs discovery of Tibetan medicine against hepatic fibrosis.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return